Garcia-Romero MT, Tollefson M, et al. Development and validation of the Morphea Activity Measure in patient with pediatric morphea. The measure consists of measuring activity in 7 body sites then summating into a score. The authors are from multiple institutions in Mexico, the United States, and Canada.
Patient selection: pediatric patient with morphea
Rules for scoring:
(1) if more than 1 lesion is present in a body region, then the most active lesion should be graded.
(2) the body surface area of all lesions in a site is used to calculate activity
Domains:
(1) new lesion
(2) enlarging over past 3 months
(3) progressive atrophy over past 6 months
(4) erythema
(5) violaceous rim
(6) warmth
(7) induration or edema (excluding sclerosis)
(8) white-yellow waxy appearance
(9) shiny white wrinkling
Parameter |
Finding |
Points |
new lesion |
no |
0 |
|
yes |
3 |
enlarging lesion |
no |
0 |
|
yes |
3 |
progressive atrophy |
no |
0 |
|
yes |
3 |
erythema |
none |
0 |
|
mild |
1 |
|
moderate |
2 |
|
severe |
3 |
violaceous rim |
none |
0 |
|
mild |
1 |
|
moderate |
2 |
|
severe |
3 |
warmth |
no |
0 |
|
yes |
1 |
induration or edema |
none |
0 |
|
mild |
1 |
|
moderate |
2 |
|
severe |
3 |
white-yellow waxy appearance |
none |
0 |
|
mild |
1 |
|
moderate |
2 |
|
severe |
3 |
shiny white wrinkling |
none |
0 |
|
mild |
1 |
|
moderate |
2 |
|
severe |
3 |
subscore for site =
= SUM(points for all of the findings)
Interpretation:
• minimum score: 0
• maximum score: 25 (theoretically; some are mutually exclusive such as enlarging and shrinking. It may be possible to combine the first 3 measures into one.
Specialty: Immunology/Rheumatology